Amphotericin B: 30 years of clinical experience.

  title={Amphotericin B: 30 years of clinical experience.},
  author={Harry A Gallis and Richard H. Drew and W W Pickard},
  journal={Reviews of infectious diseases},
  volume={12 2},
Amphotericin B, the first commercially significant antifungal drug, has been available for more than 30 years. This polyene macrolide antifungal agent continues to play a major role in the treatment of systemic fungal infections, despite the introduction of newer agents such as the azoles. Given the proved efficacy of amphotericin B--and the increasing number of indications for antifungal agents--an extensive review of this drug is warranted. This paper discusses the clinical uses of… CONTINUE READING
Highly Influential
This paper has highly influenced 12 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
238 Citations
179 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 238 extracted citations


Publications referenced by this paper.
Showing 1-10 of 179 references

Fungal peritonitis. Infect Surg 1986;January

  • BJ Hartman
  • 1986
Highly Influential
8 Excerpts

American hospital formulary servicedrug information

  • GK AmphotericinB.InMcEvoy, ed
  • American Society of Hospital Pharmacists,
  • 1988
Highly Influential
6 Excerpts

HPLC measurement of amphotericin B serum levels in cancer patients (abstract 782).Program and abstracts ofthe 27th Interscience Conference on Antimicrobial Agents and Chemotherapy

  • PowderlyWG, Granich, GP Herzid, OJ Krogstad
  • Washington DC: American Society for Microbiology,
  • 1987
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…